Phenotypic resistance testing (PhenoSense GT ®): The results indicated that the virus (HIV-1 subtype A) was sensitive to all NRTI/NNRTI and PI drugs, as by the phenotypic as genotypic interpretation (list of mutations detected: RT – V35T, T39R, E40D, K49R, V80I, Q102K, K122E, D123S, I42M, A158S, C182S, K173S, Q164K, Q197L, T200A, Q207A, R211S, E248D, A272P, R277K, T286A, E291D, V292I, P294T, L295M; PR – E35D, M36I, R41K, I62I/v, H69K, T74T/S, L89M). The combination phenotype/genotype net assessment showed that the virus was sensitive to all drugs with a virus replication capacity of 88 %. (DOC 26 kb
Frequencies of CD4+ and CD8+ T cells expressing activation and maturation markers in the peripheral ...
2 The spectrum of HIV-1 protease and reverse transcriptase (RT) mutations selected by antiretroviral...
Figure S1. Venn diagram of the differentially expressed genes (DEGs) identified from each individual...
HIV screening was performed with ARCHITECT HIV Ag/Ab Combo assay™ (ABBOTT®) for the simultaneous qua...
Titration of α4β7 inhibitors for maximal inhibition of viral replication. (A) A decreasing shift in ...
Figure S1. Validation of shRNA system for the study of HIV-1 replication. (A) Western blot detecting...
Amplification of R-gag fragments by RT-nested PCR. Longitudinally-collected vRNA samples (i.e., G1P,...
Characterisation of a responder and non-responder to ATRA treatment. CD4 cells were treated with ATR...
Table S1. Clinical characteristics and baseline immune parameters. Table S2. Repertoire and reactivi...
Figure S1. (A) gRNAs were selected for functional testing based on the number of sequences targeted ...
Additional file 4: Fig. S4. Frequencies of HLA-DR+ CD38+ CD8+ T cells that are IFN-γ+ (A), and CCCL5...
Chromosomal distribution of H3K4me3 binding sites in HIV-1 latently infected cells. Enrichment patte...
Figure S1. Squished plot of K111 PacBio sequences from patients with CTCL. The squished maps show se...
Figure S2. Highlight plot of HERV-K HML-2 3p25.3 sequences. The highlight plot displays the differen...
Figure S1. Recombination pattern of the circulant recombinant forms analyzed in this study. Box repr...
Frequencies of CD4+ and CD8+ T cells expressing activation and maturation markers in the peripheral ...
2 The spectrum of HIV-1 protease and reverse transcriptase (RT) mutations selected by antiretroviral...
Figure S1. Venn diagram of the differentially expressed genes (DEGs) identified from each individual...
HIV screening was performed with ARCHITECT HIV Ag/Ab Combo assay™ (ABBOTT®) for the simultaneous qua...
Titration of α4β7 inhibitors for maximal inhibition of viral replication. (A) A decreasing shift in ...
Figure S1. Validation of shRNA system for the study of HIV-1 replication. (A) Western blot detecting...
Amplification of R-gag fragments by RT-nested PCR. Longitudinally-collected vRNA samples (i.e., G1P,...
Characterisation of a responder and non-responder to ATRA treatment. CD4 cells were treated with ATR...
Table S1. Clinical characteristics and baseline immune parameters. Table S2. Repertoire and reactivi...
Figure S1. (A) gRNAs were selected for functional testing based on the number of sequences targeted ...
Additional file 4: Fig. S4. Frequencies of HLA-DR+ CD38+ CD8+ T cells that are IFN-γ+ (A), and CCCL5...
Chromosomal distribution of H3K4me3 binding sites in HIV-1 latently infected cells. Enrichment patte...
Figure S1. Squished plot of K111 PacBio sequences from patients with CTCL. The squished maps show se...
Figure S2. Highlight plot of HERV-K HML-2 3p25.3 sequences. The highlight plot displays the differen...
Figure S1. Recombination pattern of the circulant recombinant forms analyzed in this study. Box repr...
Frequencies of CD4+ and CD8+ T cells expressing activation and maturation markers in the peripheral ...
2 The spectrum of HIV-1 protease and reverse transcriptase (RT) mutations selected by antiretroviral...
Figure S1. Venn diagram of the differentially expressed genes (DEGs) identified from each individual...